SC101

· The First Affiliated Hospital with Nanjing Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SC101, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease [Phase 1]

See pricing